Literature DB >> 20022216

Hepatitis C and interferon induced thyroiditis.

Yaron Tomer1.   

Abstract

Autoimmune thyroid diseases (AITDs) are complex diseases that develop as a result of interactions between genetic, epigenetic, and environmental factors. Significant progress has been made in our understanding of the genetic and environmental triggers contributing to AITD. The major environmental triggers of AITD include iodine, smoking, medications, pregnancy, and possibly stress. In this review we will focus on two well-documented environmental triggers of AITD, hepatitis C virus (HCV) infection and interferon alpha (IFNa) therapy. Chronic HCV infection has been shown to be associated with increased incidence of clinical and subclinical autoimmune thyroiditis (i.e. the presence of thyroid antibodies in euthyroid subjects). Moreover, IFNa therapy of chronic HCV infection is associated with subclinical or clinical thyroiditis in up to 40% of cases which can be autoimmune, or non-autoimmune thyroiditis. In some cases interferon induced thyroiditis (IIT) in chronic HCV patients may result in severe symptomatology necessitating discontinuation of therapy. While the epidemiology and clinical presentation of HCV and interferon induced thyroiditis have been well characterized, the mechanisms causing these conditions are still poorly understood. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20022216      PMCID: PMC2835812          DOI: 10.1016/j.jaut.2009.11.008

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  89 in total

Review 1.  New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine.

Authors:  H Tilg
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

2.  Effects of interferon-alpha (IFN-alpha) administration on leucocytes in healthy humans.

Authors:  E P Corssmit; R Heijligenberg; C E Hack; E Endert; H P Sauerwein; J A Romijn
Journal:  Clin Exp Immunol       Date:  1997-02       Impact factor: 4.330

3.  The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.

Authors:  J B Jaspan; K Sullivan; R F Garry; M Lopez; M Wolfe; S Clejan; C Yan; S Tenenbaum; D M Sander; B Ahmed; M Bryer-Ash
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

4.  Evidence for a retroviral trigger in Graves' disease.

Authors:  J B Jaspan; H Luo; B Ahmed; S Tenenbaum; T Voss; D M Sander; K Bollinger; T Baquet; R F Garry
Journal:  Autoimmunity       Date:  1995       Impact factor: 2.815

5.  Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.

Authors:  M Marazuela; L García-Buey; B González-Fernández; C García-Monzón; A Arranz; M J Borque; R Moreno-Otero
Journal:  Clin Endocrinol (Oxf)       Date:  1996-06       Impact factor: 3.478

6.  Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.

Authors:  E Roti; R Minelli; T Giuberti; S Marchelli; C Schianchi; E Gardini; M Salvi; F Fiaccadori; G Ugolotti; T M Neri; L E Braverman
Journal:  Am J Med       Date:  1996-11       Impact factor: 4.965

7.  Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.

Authors:  C Carella; G Amato; B Biondi; M Rotondi; F Morisco; C Tuccillo; N Chiuchiolo; G Signoriello; N Caporaso; G Lombardi
Journal:  Horm Res       Date:  1995

8.  Presence of human T-lymphotropic virus type II-related genes in DNA of peripheral leukocytes from patients with autoimmune thyroid diseases.

Authors:  K Yokoi; H Kawai; M Akaike; H Mine; S Saito
Journal:  J Med Virol       Date:  1995-04       Impact factor: 2.327

9.  Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection.

Authors:  J Boadas; J Rodríguez-Espinosa; J Enríquez; F Miralles; F J Martínez-Cerezo; P González; P Madoz; F Vilardell
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

10.  Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.

Authors:  D Preziati; L La Rosa; G Covini; R Marcelli; S Rescalli; L Persani; E Del Ninno; P L Meroni; M Colombo; P Beck-Peccoz
Journal:  Eur J Endocrinol       Date:  1995-05       Impact factor: 6.664

View more
  40 in total

1.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

Review 2.  Drug-induced lupus erythematosus: incidence, management and prevention.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 3.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

4.  The persistent challenge of lupus nephritis.

Authors:  Guido Valesini; Fabrizio Conti
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

5.  Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors.

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

6.  Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism.

Authors:  Mihaela Stefan; Eric M Jacobson; Amanda K Huber; David A Greenberg; Cheuk Wun Li; Luce Skrabanek; Erlinda Conception; Mohammed Fadlalla; Kenneth Ho; Yaron Tomer
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

7.  Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.

Authors:  Balaji B Ganesh; Palash Bhattacharya; Anupama Gopisetty; Bellur S Prabhakar
Journal:  J Interferon Cytokine Res       Date:  2011-08-08       Impact factor: 2.607

8.  Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.

Authors:  Yinon Shapira; Bat-Sheva Poratkatz; Boris Gilburd; Ori Barzilai; Maya Ram; Miri Blank; Staffan Lindeberg; Johan Frostegård; Juan-Manuel Anaya; Nicola Bizzaro; Luis J Jara; Jan Damoiseaux; Yehuda Shoenfeld; Nancy Agmon Levin
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

9.  Thyroid autoantibodies are rare in nonhuman great apes and hypothyroidism cannot be attributed to thyroid autoimmunity.

Authors:  Holly Aliesky; Cynthia L Courtney; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

Review 10.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.